nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—pleura—esophageal cancer	0.254	0.569	CbGeAlD
Misoprostol—PTGER4—epithelium—esophageal cancer	0.0211	0.0472	CbGeAlD
Misoprostol—PTGER4—bronchus—esophageal cancer	0.0208	0.0465	CbGeAlD
Misoprostol—PTGER4—smooth muscle tissue—esophageal cancer	0.0203	0.0455	CbGeAlD
Misoprostol—PTGER2—trachea—esophageal cancer	0.019	0.0425	CbGeAlD
Misoprostol—PTGER3—smooth muscle tissue—esophageal cancer	0.0172	0.0385	CbGeAlD
Misoprostol—PTGER4—digestive system—esophageal cancer	0.0161	0.0359	CbGeAlD
Misoprostol—Foetal death—Methotrexate—esophageal cancer	0.0156	0.0531	CcSEcCtD
Misoprostol—PTGER2—lung—esophageal cancer	0.0137	0.0306	CbGeAlD
Misoprostol—PTGER3—digestive system—esophageal cancer	0.0136	0.0304	CbGeAlD
Misoprostol—PTGER4—lung—esophageal cancer	0.0134	0.03	CbGeAlD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.0124	0.0482	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.0122	0.0472	CbGpPWpGaD
Misoprostol—PTGER3—lung—esophageal cancer	0.0114	0.0254	CbGeAlD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.0102	0.0396	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.01	0.0388	CbGpPWpGaD
Misoprostol—Phlebitis—Carboplatin—esophageal cancer	0.00944	0.0321	CcSEcCtD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.00941	0.0365	CbGpPWpGaD
Misoprostol—PTGER2—lymph node—esophageal cancer	0.00935	0.0209	CbGeAlD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.00923	0.0358	CbGpPWpGaD
Misoprostol—PTGER4—lymph node—esophageal cancer	0.00917	0.0205	CbGeAlD
Misoprostol—Thromboembolic event—Capecitabine—esophageal cancer	0.00899	0.0305	CcSEcCtD
Misoprostol—PTGER4—G alpha (s) signalling events—ADCYAP1—esophageal cancer	0.00852	0.0331	CbGpPWpGaD
Misoprostol—PTGER3—lymph node—esophageal cancer	0.00777	0.0174	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—CYP19A1—esophageal cancer	0.00774	0.03	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—ADCYAP1—esophageal cancer	0.007	0.0272	CbGpPWpGaD
Misoprostol—Thromboembolic event—Methotrexate—esophageal cancer	0.00669	0.0227	CcSEcCtD
Misoprostol—Arterial thrombosis—Methotrexate—esophageal cancer	0.00669	0.0227	CcSEcCtD
Misoprostol—Congenital anomaly—Capecitabine—esophageal cancer	0.00637	0.0216	CcSEcCtD
Misoprostol—Developmental delay—Capecitabine—esophageal cancer	0.00637	0.0216	CcSEcCtD
Misoprostol—PTGER4—G alpha (s) signalling events—PDE4D—esophageal cancer	0.00502	0.0195	CbGpPWpGaD
Misoprostol—Rectal disorder—Capecitabine—esophageal cancer	0.00494	0.0168	CcSEcCtD
Misoprostol—PTGER4—G alpha (s) signalling events—GNG7—esophageal cancer	0.00478	0.0185	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00476	0.0185	CbGpPWpGaD
Misoprostol—Anorectal disorder—Capecitabine—esophageal cancer	0.00461	0.0156	CcSEcCtD
Misoprostol—PTGER2—G alpha (s) signalling events—PDE4D—esophageal cancer	0.00412	0.016	CbGpPWpGaD
Misoprostol—Infection—Carboplatin—esophageal cancer	0.00397	0.0135	CcSEcCtD
Misoprostol—PTGER2—G alpha (s) signalling events—GNG7—esophageal cancer	0.00392	0.0152	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00391	0.0152	CbGpPWpGaD
Misoprostol—Loss of libido—Methotrexate—esophageal cancer	0.00391	0.0133	CcSEcCtD
Misoprostol—Embolism—Capecitabine—esophageal cancer	0.00377	0.0128	CcSEcCtD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.00361	0.014	CbGpPWpGaD
Misoprostol—Pain—Carboplatin—esophageal cancer	0.00342	0.0116	CcSEcCtD
Misoprostol—Metrorrhagia—Capecitabine—esophageal cancer	0.00339	0.0115	CcSEcCtD
Misoprostol—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00327	0.0111	CcSEcCtD
Misoprostol—Body temperature increased—Carboplatin—esophageal cancer	0.00316	0.0107	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00309	0.012	CbGpPWpGaD
Misoprostol—Neuropathy—Cisplatin—esophageal cancer	0.00308	0.0105	CcSEcCtD
Misoprostol—Rigors—Capecitabine—esophageal cancer	0.00297	0.0101	CcSEcCtD
Misoprostol—Embolism—Methotrexate—esophageal cancer	0.00281	0.00954	CcSEcCtD
Misoprostol—Phlebitis—Cisplatin—esophageal cancer	0.00277	0.0094	CcSEcCtD
Misoprostol—Polyuria—Cisplatin—esophageal cancer	0.00272	0.00923	CcSEcCtD
Misoprostol—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.0027	0.00917	CcSEcCtD
Misoprostol—Deafness—Cisplatin—esophageal cancer	0.00267	0.00906	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00254	0.00986	CbGpPWpGaD
Misoprostol—Inflammation—Capecitabine—esophageal cancer	0.0025	0.00848	CcSEcCtD
Misoprostol—Pulmonary embolism—Capecitabine—esophageal cancer	0.00242	0.00823	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00242	0.00823	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00239	0.0081	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00234	0.0091	CbGpPWpGaD
Misoprostol—Gingivitis—Methotrexate—esophageal cancer	0.0023	0.0078	CcSEcCtD
Misoprostol—Neuropathy—Capecitabine—esophageal cancer	0.00227	0.00772	CcSEcCtD
Misoprostol—Dehydration—Cisplatin—esophageal cancer	0.00222	0.00753	CcSEcCtD
Misoprostol—Urine output increased—Capecitabine—esophageal cancer	0.00219	0.00744	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—GNG7—esophageal cancer	0.00217	0.00842	CbGpPWpGaD
Misoprostol—Breast disorder—Cisplatin—esophageal cancer	0.00216	0.00732	CcSEcCtD
Misoprostol—Cramp muscle—Cisplatin—esophageal cancer	0.00215	0.00729	CcSEcCtD
Misoprostol—Abnormal vision—Capecitabine—esophageal cancer	0.00211	0.00717	CcSEcCtD
Misoprostol—Ear pain—Capecitabine—esophageal cancer	0.00206	0.007	CcSEcCtD
Misoprostol—Phlebitis—Capecitabine—esophageal cancer	0.00204	0.00693	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00202	0.00687	CcSEcCtD
Misoprostol—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00201	0.00683	CcSEcCtD
Misoprostol—Sweating increased—Cisplatin—esophageal cancer	0.00201	0.00682	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00201	0.00779	CbGpPWpGaD
Misoprostol—Polyuria—Capecitabine—esophageal cancer	0.002	0.0068	CcSEcCtD
Misoprostol—Deafness—Capecitabine—esophageal cancer	0.00197	0.00668	CcSEcCtD
Misoprostol—Vascular purpura—Capecitabine—esophageal cancer	0.00197	0.00668	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL2—esophageal cancer	0.00191	0.00742	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00187	0.00724	CbGpPWpGaD
Misoprostol—Inflammation—Methotrexate—esophageal cancer	0.00186	0.00631	CcSEcCtD
Misoprostol—Thirst—Capecitabine—esophageal cancer	0.00185	0.00627	CcSEcCtD
Misoprostol—Purpura—Capecitabine—esophageal cancer	0.00182	0.0062	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00181	0.00704	CbGpPWpGaD
Misoprostol—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00181	0.00615	CcSEcCtD
Misoprostol—Pulmonary embolism—Methotrexate—esophageal cancer	0.0018	0.00612	CcSEcCtD
Misoprostol—Myocardial infarction—Cisplatin—esophageal cancer	0.0018	0.00612	CcSEcCtD
Misoprostol—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0018	0.00612	CcSEcCtD
Misoprostol—Conjunctivitis—Cisplatin—esophageal cancer	0.00179	0.00607	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—ANXA1—esophageal cancer	0.00178	0.0069	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00177	0.00686	CbGpPWpGaD
Misoprostol—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00176	0.00597	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00175	0.00678	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—GNG7—esophageal cancer	0.00173	0.00673	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—SST—esophageal cancer	0.00173	0.00671	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00165	0.00639	CbGpPWpGaD
Misoprostol—Dehydration—Capecitabine—esophageal cancer	0.00164	0.00555	CcSEcCtD
Misoprostol—Urine output increased—Methotrexate—esophageal cancer	0.00163	0.00554	CcSEcCtD
Misoprostol—Visual impairment—Cisplatin—esophageal cancer	0.00159	0.0054	CcSEcCtD
Misoprostol—Breast disorder—Capecitabine—esophageal cancer	0.00159	0.0054	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00159	0.00616	CbGpPWpGaD
Misoprostol—Tinnitus—Cisplatin—esophageal cancer	0.00154	0.00522	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00153	0.00594	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL2—esophageal cancer	0.00153	0.00593	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00152	0.0059	CbGpPWpGaD
Misoprostol—Dysphagia—Capecitabine—esophageal cancer	0.00152	0.00516	CcSEcCtD
Misoprostol—Bronchospasm—Capecitabine—esophageal cancer	0.00149	0.00508	CcSEcCtD
Misoprostol—Polyuria—Methotrexate—esophageal cancer	0.00149	0.00506	CcSEcCtD
Misoprostol—Immune system disorder—Cisplatin—esophageal cancer	0.00149	0.00506	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00149	0.00578	CbGpPWpGaD
Misoprostol—Sweating increased—Capecitabine—esophageal cancer	0.00148	0.00503	CcSEcCtD
Misoprostol—Arrhythmia—Cisplatin—esophageal cancer	0.00147	0.00501	CcSEcCtD
Misoprostol—Bronchitis—Capecitabine—esophageal cancer	0.00146	0.00496	CcSEcCtD
Misoprostol—Alopecia—Cisplatin—esophageal cancer	0.00146	0.00495	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—GDI2—esophageal cancer	0.00146	0.00565	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00145	0.00564	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00144	0.00557	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—GNG7—esophageal cancer	0.00142	0.00553	CbGpPWpGaD
Misoprostol—Dysuria—Capecitabine—esophageal cancer	0.00142	0.00483	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—ANXA1—esophageal cancer	0.00142	0.00551	CbGpPWpGaD
Misoprostol—Flatulence—Cisplatin—esophageal cancer	0.00142	0.00481	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00141	0.00549	CbGpPWpGaD
Misoprostol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00141	0.0048	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—SST—esophageal cancer	0.00138	0.00536	CbGpPWpGaD
Misoprostol—Muscle spasms—Cisplatin—esophageal cancer	0.00138	0.00469	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00138	0.00534	CbGpPWpGaD
Misoprostol—Pneumonia—Capecitabine—esophageal cancer	0.00136	0.00463	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—GHRL—esophageal cancer	0.00135	0.00523	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00134	0.0052	CbGpPWpGaD
Misoprostol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00134	0.00454	CcSEcCtD
Misoprostol—Myocardial infarction—Capecitabine—esophageal cancer	0.00133	0.00451	CcSEcCtD
Misoprostol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00133	0.00451	CcSEcCtD
Misoprostol—Anaemia—Cisplatin—esophageal cancer	0.00133	0.00451	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00132	0.00514	CbGpPWpGaD
Misoprostol—Conjunctivitis—Capecitabine—esophageal cancer	0.00132	0.00447	CcSEcCtD
Misoprostol—Urinary tract infection—Capecitabine—esophageal cancer	0.00132	0.00447	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—GNG7—esophageal cancer	0.00131	0.0051	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—ADCYAP1—esophageal cancer	0.0013	0.00506	CbGpPWpGaD
Misoprostol—Haematuria—Capecitabine—esophageal cancer	0.00129	0.00439	CcSEcCtD
Misoprostol—Epistaxis—Capecitabine—esophageal cancer	0.00128	0.00434	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CXCL2—esophageal cancer	0.00125	0.00487	CbGpPWpGaD
Misoprostol—Myalgia—Cisplatin—esophageal cancer	0.00122	0.00415	CcSEcCtD
Misoprostol—Anxiety—Cisplatin—esophageal cancer	0.00122	0.00414	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—ADCYAP1—esophageal cancer	0.0012	0.00467	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GDI2—esophageal cancer	0.0012	0.00464	CbGpPWpGaD
Misoprostol—Breast disorder—Methotrexate—esophageal cancer	0.00118	0.00402	CcSEcCtD
Misoprostol—Oedema—Cisplatin—esophageal cancer	0.00117	0.00398	CcSEcCtD
Misoprostol—Anaphylactic shock—Cisplatin—esophageal cancer	0.00117	0.00398	CcSEcCtD
Misoprostol—Visual impairment—Capecitabine—esophageal cancer	0.00117	0.00398	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—ANXA1—esophageal cancer	0.00117	0.00453	CbGpPWpGaD
Misoprostol—Infection—Cisplatin—esophageal cancer	0.00116	0.00396	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CXCL2—esophageal cancer	0.00116	0.00449	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Cisplatin—esophageal cancer	0.00115	0.0039	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—SST—esophageal cancer	0.00113	0.0044	CbGpPWpGaD
Misoprostol—Tinnitus—Capecitabine—esophageal cancer	0.00113	0.00385	CcSEcCtD
Misoprostol—Hyperhidrosis—Cisplatin—esophageal cancer	0.00113	0.00385	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—AKAP13—esophageal cancer	0.00113	0.00437	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—GHRL—esophageal cancer	0.00111	0.00429	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GDI2—esophageal cancer	0.0011	0.00428	CbGpPWpGaD
Misoprostol—Immune system disorder—Capecitabine—esophageal cancer	0.0011	0.00373	CcSEcCtD
Misoprostol—Hypotension—Cisplatin—esophageal cancer	0.0011	0.00372	CcSEcCtD
Misoprostol—Chills—Capecitabine—esophageal cancer	0.00109	0.00371	CcSEcCtD
Misoprostol—Arrhythmia—Capecitabine—esophageal cancer	0.00109	0.00369	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—ANXA1—esophageal cancer	0.00108	0.00418	CbGpPWpGaD
Misoprostol—Alopecia—Capecitabine—esophageal cancer	0.00107	0.00365	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00107	0.00363	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—esophageal cancer	0.00106	0.00359	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—KMT2D—esophageal cancer	0.00105	0.00408	CbGpPWpGaD
Misoprostol—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00105	0.00357	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—SST—esophageal cancer	0.00105	0.00406	CbGpPWpGaD
Misoprostol—Dyspnoea—Cisplatin—esophageal cancer	0.00105	0.00355	CcSEcCtD
Misoprostol—Flatulence—Capecitabine—esophageal cancer	0.00104	0.00354	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—esophageal cancer	0.00104	0.00354	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PDE4D—esophageal cancer	0.00103	0.004	CbGpPWpGaD
Misoprostol—Back pain—Capecitabine—esophageal cancer	0.00102	0.00348	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—AKAP13—esophageal cancer	0.00102	0.00397	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—GHRL—esophageal cancer	0.00102	0.00396	CbGpPWpGaD
Misoprostol—Muscle spasms—Capecitabine—esophageal cancer	0.00102	0.00346	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—esophageal cancer	0.00101	0.00345	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—esophageal cancer	0.00101	0.00343	CcSEcCtD
Misoprostol—Pain—Cisplatin—esophageal cancer	0.001	0.0034	CcSEcCtD
Misoprostol—Conjunctivitis—Methotrexate—esophageal cancer	0.00098	0.00333	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—GNG7—esophageal cancer	0.00098	0.0038	CbGpPWpGaD
Misoprostol—Anaemia—Capecitabine—esophageal cancer	0.000979	0.00332	CcSEcCtD
Misoprostol—Feeling abnormal—Cisplatin—esophageal cancer	0.000966	0.00328	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—esophageal cancer	0.000962	0.00327	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—esophageal cancer	0.000951	0.00323	CcSEcCtD
Misoprostol—Syncope—Capecitabine—esophageal cancer	0.00095	0.00322	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—ADCYAP1—esophageal cancer	0.000938	0.00364	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PDE4D—esophageal cancer	0.000936	0.00363	CbGpPWpGaD
Misoprostol—Loss of consciousness—Capecitabine—esophageal cancer	0.000931	0.00316	CcSEcCtD
Misoprostol—Body temperature increased—Cisplatin—esophageal cancer	0.000927	0.00315	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000925	0.00359	CbGpPWpGaD
Misoprostol—Hypertension—Capecitabine—esophageal cancer	0.000914	0.0031	CcSEcCtD
Misoprostol—Myalgia—Capecitabine—esophageal cancer	0.000901	0.00306	CcSEcCtD
Misoprostol—Chest pain—Capecitabine—esophageal cancer	0.000901	0.00306	CcSEcCtD
Misoprostol—Arthralgia—Capecitabine—esophageal cancer	0.000901	0.00306	CcSEcCtD
Misoprostol—Anxiety—Capecitabine—esophageal cancer	0.000898	0.00305	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—GNG7—esophageal cancer	0.00089	0.00345	CbGpPWpGaD
Misoprostol—Visual impairment—Methotrexate—esophageal cancer	0.000873	0.00296	CcSEcCtD
Misoprostol—Confusional state—Capecitabine—esophageal cancer	0.000871	0.00296	CcSEcCtD
Misoprostol—Oedema—Capecitabine—esophageal cancer	0.000864	0.00293	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—KMT2D—esophageal cancer	0.000864	0.00335	CbGpPWpGaD
Misoprostol—Hypersensitivity—Cisplatin—esophageal cancer	0.000864	0.00293	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL2—esophageal cancer	0.000863	0.00335	CbGpPWpGaD
Misoprostol—Infection—Capecitabine—esophageal cancer	0.000858	0.00292	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—WWOX—esophageal cancer	0.000858	0.00333	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKAP13—esophageal cancer	0.000854	0.00331	CbGpPWpGaD
Misoprostol—Shock—Capecitabine—esophageal cancer	0.00085	0.00289	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000846	0.00328	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Capecitabine—esophageal cancer	0.000846	0.00287	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—esophageal cancer	0.000844	0.00287	CcSEcCtD
Misoprostol—Asthenia—Cisplatin—esophageal cancer	0.000841	0.00286	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—AKAP13—esophageal cancer	0.00084	0.00326	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Capecitabine—esophageal cancer	0.000835	0.00284	CcSEcCtD
Misoprostol—Immune system disorder—Methotrexate—esophageal cancer	0.000818	0.00278	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FKBP1A—esophageal cancer	0.000816	0.00317	CbGpPWpGaD
Misoprostol—Chills—Methotrexate—esophageal cancer	0.000812	0.00276	CcSEcCtD
Misoprostol—Hypotension—Capecitabine—esophageal cancer	0.000807	0.00274	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—GNG7—esophageal cancer	0.000805	0.00312	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—ANXA1—esophageal cancer	0.000803	0.00312	CbGpPWpGaD
Misoprostol—Diarrhoea—Cisplatin—esophageal cancer	0.000802	0.00272	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—esophageal cancer	0.0008	0.00272	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—KMT2D—esophageal cancer	0.000797	0.00309	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—WIF1—esophageal cancer	0.000797	0.00309	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000787	0.00267	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CXCL2—esophageal cancer	0.000784	0.00304	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PDE4D—esophageal cancer	0.000781	0.00303	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—SST—esophageal cancer	0.000781	0.00303	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKAP13—esophageal cancer	0.000775	0.00301	CbGpPWpGaD
Misoprostol—Dyspnoea—Capecitabine—esophageal cancer	0.00077	0.00262	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—ADCYAP1—esophageal cancer	0.00077	0.00299	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PDE4D—esophageal cancer	0.000768	0.00298	CbGpPWpGaD
Misoprostol—Back pain—Methotrexate—esophageal cancer	0.000762	0.00259	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—GHRL—esophageal cancer	0.000761	0.00295	CbGpPWpGaD
Misoprostol—Dyspepsia—Capecitabine—esophageal cancer	0.000761	0.00258	CcSEcCtD
Misoprostol—Vomiting—Cisplatin—esophageal cancer	0.000745	0.00253	CcSEcCtD
Misoprostol—Fatigue—Capecitabine—esophageal cancer	0.000745	0.00253	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—GNG7—esophageal cancer	0.000743	0.00288	CbGpPWpGaD
Misoprostol—Rash—Cisplatin—esophageal cancer	0.000739	0.00251	CcSEcCtD
Misoprostol—Pain—Capecitabine—esophageal cancer	0.000739	0.00251	CcSEcCtD
Misoprostol—Constipation—Capecitabine—esophageal cancer	0.000739	0.00251	CcSEcCtD
Misoprostol—Dermatitis—Cisplatin—esophageal cancer	0.000738	0.00251	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CSNK1A1—esophageal cancer	0.000736	0.00286	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—GNG7—esophageal cancer	0.000731	0.00284	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—ANXA1—esophageal cancer	0.000729	0.00283	CbGpPWpGaD
Misoprostol—Anaemia—Methotrexate—esophageal cancer	0.000729	0.00247	CcSEcCtD
Misoprostol—Feeling abnormal—Capecitabine—esophageal cancer	0.000712	0.00242	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ADCYAP1—esophageal cancer	0.000711	0.00276	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PDE4D—esophageal cancer	0.000709	0.00275	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—SST—esophageal cancer	0.000709	0.00275	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000709	0.00275	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000707	0.0024	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—WWOX—esophageal cancer	0.000704	0.00273	CbGpPWpGaD
Misoprostol—Nausea—Cisplatin—esophageal cancer	0.000696	0.00236	CcSEcCtD
Misoprostol—Dinoprostone—CYP19A1—esophageal cancer	0.000695	1	CrCbGaD
Misoprostol—PTGER4—Signaling by GPCR—GHRL—esophageal cancer	0.000691	0.00268	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PFN1—esophageal cancer	0.000688	0.00267	CbGpPWpGaD
Misoprostol—Abdominal pain—Capecitabine—esophageal cancer	0.000683	0.00232	CcSEcCtD
Misoprostol—Body temperature increased—Capecitabine—esophageal cancer	0.000683	0.00232	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—GNG7—esophageal cancer	0.000675	0.00262	CbGpPWpGaD
Misoprostol—Arthralgia—Methotrexate—esophageal cancer	0.000671	0.00228	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—esophageal cancer	0.000671	0.00228	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—esophageal cancer	0.000671	0.00228	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FKBP1A—esophageal cancer	0.00067	0.0026	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000659	0.00256	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—WIF1—esophageal cancer	0.000655	0.00254	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL2—esophageal cancer	0.000654	0.00254	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—WWOX—esophageal cancer	0.00065	0.00252	CbGpPWpGaD
Misoprostol—Confusional state—Methotrexate—esophageal cancer	0.000649	0.0022	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CXCL2—esophageal cancer	0.000644	0.0025	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Methotrexate—esophageal cancer	0.000643	0.00218	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—SST—esophageal cancer	0.000641	0.00249	CbGpPWpGaD
Misoprostol—Infection—Methotrexate—esophageal cancer	0.000639	0.00217	CcSEcCtD
Misoprostol—Hypersensitivity—Capecitabine—esophageal cancer	0.000637	0.00216	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—esophageal cancer	0.00063	0.00214	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—GHRL—esophageal cancer	0.000625	0.00243	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Methotrexate—esophageal cancer	0.000622	0.00211	CcSEcCtD
Misoprostol—Asthenia—Capecitabine—esophageal cancer	0.00062	0.00211	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—ELMO1—esophageal cancer	0.000618	0.0024	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FKBP1A—esophageal cancer	0.000618	0.0024	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—ANXA1—esophageal cancer	0.000608	0.00236	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000604	0.00235	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—WIF1—esophageal cancer	0.000604	0.00235	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKAP13—esophageal cancer	0.000604	0.00235	CbGpPWpGaD
Misoprostol—Hypotension—Methotrexate—esophageal cancer	0.000601	0.00204	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—ANXA1—esophageal cancer	0.000599	0.00232	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL2—esophageal cancer	0.000594	0.00231	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—SST—esophageal cancer	0.000592	0.0023	CbGpPWpGaD
Misoprostol—Diarrhoea—Capecitabine—esophageal cancer	0.000591	0.00201	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000586	0.00199	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—SST—esophageal cancer	0.000582	0.00226	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—GHRL—esophageal cancer	0.000577	0.00224	CbGpPWpGaD
Misoprostol—Dyspnoea—Methotrexate—esophageal cancer	0.000574	0.00195	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—esophageal cancer	0.000572	0.00194	CcSEcCtD
Misoprostol—Dizziness—Capecitabine—esophageal cancer	0.000571	0.00194	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—GHRL—esophageal cancer	0.000568	0.0022	CbGpPWpGaD
Misoprostol—Dyspepsia—Methotrexate—esophageal cancer	0.000566	0.00192	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PFN1—esophageal cancer	0.000565	0.00219	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000558	0.00216	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000558	0.00216	CbGpPWpGaD
Misoprostol—Fatigue—Methotrexate—esophageal cancer	0.000555	0.00188	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PDE4D—esophageal cancer	0.000553	0.00214	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—ANXA1—esophageal cancer	0.000552	0.00214	CbGpPWpGaD
Misoprostol—Pain—Methotrexate—esophageal cancer	0.00055	0.00187	CcSEcCtD
Misoprostol—Vomiting—Capecitabine—esophageal cancer	0.000549	0.00187	CcSEcCtD
Misoprostol—Rash—Capecitabine—esophageal cancer	0.000545	0.00185	CcSEcCtD
Misoprostol—Dermatitis—Capecitabine—esophageal cancer	0.000544	0.00185	CcSEcCtD
Misoprostol—Headache—Capecitabine—esophageal cancer	0.000541	0.00184	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—SST—esophageal cancer	0.000537	0.00209	CbGpPWpGaD
Misoprostol—Feeling abnormal—Methotrexate—esophageal cancer	0.00053	0.0018	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000526	0.00179	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—GNG7—esophageal cancer	0.000526	0.00204	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—GHRL—esophageal cancer	0.000524	0.00203	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PFN1—esophageal cancer	0.000522	0.00202	CbGpPWpGaD
Misoprostol—Nausea—Capecitabine—esophageal cancer	0.000513	0.00174	CcSEcCtD
Misoprostol—Abdominal pain—Methotrexate—esophageal cancer	0.000509	0.00173	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—esophageal cancer	0.000509	0.00173	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—ELMO1—esophageal cancer	0.000508	0.00197	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKAP13—esophageal cancer	0.000496	0.00193	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—XIAP—esophageal cancer	0.000493	0.00191	CbGpPWpGaD
Misoprostol—Hypersensitivity—Methotrexate—esophageal cancer	0.000474	0.00161	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ELMO1—esophageal cancer	0.000469	0.00182	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNA1—esophageal cancer	0.000466	0.00181	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL2—esophageal cancer	0.000463	0.0018	CbGpPWpGaD
Misoprostol—Asthenia—Methotrexate—esophageal cancer	0.000462	0.00157	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000458	0.00178	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKAP13—esophageal cancer	0.000458	0.00178	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PDE4D—esophageal cancer	0.000454	0.00176	CbGpPWpGaD
Misoprostol—Diarrhoea—Methotrexate—esophageal cancer	0.00044	0.00149	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PSME2—esophageal cancer	0.000433	0.00168	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PSME1—esophageal cancer	0.000433	0.00168	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GNG7—esophageal cancer	0.000432	0.00168	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ANXA1—esophageal cancer	0.000431	0.00167	CbGpPWpGaD
Misoprostol—Dizziness—Methotrexate—esophageal cancer	0.000425	0.00144	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000423	0.00164	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SST—esophageal cancer	0.000419	0.00163	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDE4D—esophageal cancer	0.000419	0.00163	CbGpPWpGaD
Misoprostol—Vomiting—Methotrexate—esophageal cancer	0.000409	0.00139	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—GHRL—esophageal cancer	0.000408	0.00158	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOTCH3—esophageal cancer	0.000408	0.00158	CbGpPWpGaD
Misoprostol—Rash—Methotrexate—esophageal cancer	0.000406	0.00138	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—esophageal cancer	0.000405	0.00138	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—XIAP—esophageal cancer	0.000405	0.00157	CbGpPWpGaD
Misoprostol—Headache—Methotrexate—esophageal cancer	0.000403	0.00137	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FBXW7—esophageal cancer	0.000402	0.00156	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GNG7—esophageal cancer	0.000398	0.00155	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNA1—esophageal cancer	0.000383	0.00148	CbGpPWpGaD
Misoprostol—Nausea—Methotrexate—esophageal cancer	0.000382	0.0013	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CXCL2—esophageal cancer	0.00038	0.00148	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—XIAP—esophageal cancer	0.000373	0.00145	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOTCH2—esophageal cancer	0.000366	0.00142	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSME2—esophageal cancer	0.000355	0.00138	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSME1—esophageal cancer	0.000355	0.00138	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ANXA1—esophageal cancer	0.000354	0.00137	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNA1—esophageal cancer	0.000353	0.00137	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL2—esophageal cancer	0.000351	0.00136	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SST—esophageal cancer	0.000344	0.00133	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOTCH3—esophageal cancer	0.000335	0.0013	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GHRL—esophageal cancer	0.000335	0.0013	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FBXW7—esophageal cancer	0.00033	0.00128	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSME2—esophageal cancer	0.000328	0.00127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSME1—esophageal cancer	0.000328	0.00127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ANXA1—esophageal cancer	0.000326	0.00127	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFBR2—esophageal cancer	0.000325	0.00126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SST—esophageal cancer	0.000317	0.00123	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GHRL—esophageal cancer	0.000309	0.0012	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH3—esophageal cancer	0.000309	0.0012	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SMAD4—esophageal cancer	0.000307	0.00119	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FBXW7—esophageal cancer	0.000304	0.00118	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOTCH2—esophageal cancer	0.000301	0.00117	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH2—esophageal cancer	0.000277	0.00108	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFBR2—esophageal cancer	0.000267	0.00104	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SMAD4—esophageal cancer	0.000252	0.00098	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HIF1A—esophageal cancer	0.000252	0.000976	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFBR2—esophageal cancer	0.000246	0.000955	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KDR—esophageal cancer	0.000241	0.000934	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SMAD4—esophageal cancer	0.000233	0.000904	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOTCH1—esophageal cancer	0.000227	0.00088	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HIF1A—esophageal cancer	0.000207	0.000802	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CREBBP—esophageal cancer	0.000205	0.000797	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—esophageal cancer	0.000202	0.000784	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KDR—esophageal cancer	0.000198	0.000767	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000193	0.000749	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HIF1A—esophageal cancer	0.000191	0.00074	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOTCH1—esophageal cancer	0.000186	0.000722	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOS3—esophageal cancer	0.000184	0.000714	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KDR—esophageal cancer	0.000182	0.000708	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—esophageal cancer	0.000175	0.00068	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB2—esophageal cancer	0.000172	0.000668	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOTCH1—esophageal cancer	0.000172	0.000667	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CREBBP—esophageal cancer	0.000169	0.000655	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—esophageal cancer	0.000166	0.000643	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000158	0.000615	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CREBBP—esophageal cancer	0.000156	0.000604	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—esophageal cancer	0.000153	0.000594	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—esophageal cancer	0.000152	0.00059	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOS3—esophageal cancer	0.000151	0.000586	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1A—esophageal cancer	0.000147	0.000571	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000146	0.000568	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000144	0.000558	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB2—esophageal cancer	0.000141	0.000548	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EP300—esophageal cancer	0.00014	0.000543	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOS3—esophageal cancer	0.000139	0.000541	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—esophageal cancer	0.000133	0.000515	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB2—esophageal cancer	0.00013	0.000506	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—esophageal cancer	0.000125	0.000485	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—esophageal cancer	0.000122	0.000473	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1A—esophageal cancer	0.000121	0.000469	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—esophageal cancer	0.000119	0.000463	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—esophageal cancer	0.000115	0.000447	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EP300—esophageal cancer	0.000115	0.000446	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1A—esophageal cancer	0.000111	0.000433	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EP300—esophageal cancer	0.000106	0.000412	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—esophageal cancer	0.000104	0.000402	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—esophageal cancer	0.0001	0.000389	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—esophageal cancer	0.0001	0.000389	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—esophageal cancer	9.8e-05	0.00038	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—esophageal cancer	9.24e-05	0.000359	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—esophageal cancer	9.04e-05	0.000351	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—esophageal cancer	8.5e-05	0.00033	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—esophageal cancer	8.22e-05	0.000319	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—esophageal cancer	7.85e-05	0.000304	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—esophageal cancer	7.59e-05	0.000295	CbGpPWpGaD
